T46.0X5
Adverse effect of cardiac-stimulant glycosides and drugs of similar action
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code T46.0X5 pertains to adverse effects caused by cardiac-stimulant glycosides and similar drugs. Cardiac stimulants, also known as inotropic agents, are medications used to improve heart function, especially in conditions like heart failure. While these medications can be beneficial, they may sometimes lead to unwanted side effects. Recognizing these adverse effects is important for effective management and ensuring patient safety.
Causes & Symptoms
Clinical Causes: Overdose or excessive dosing of cardiac-stimulant glycosides Drug interactions that increase toxicity Impaired renal or hepatic function affecting drug metabolism Sensitivity or allergic reactions to the medication Incorrect administration or formulation errors
Key Symptoms: Nausea and vomiting Dizziness or lightheadedness Visual disturbances, such as blurred vision or halos Irregular heartbeat (arrhythmias) Electrolyte imbalances, including hypokalemia or hypomagnesemia Weakness or fatigue Confusion or disturbed mental status Chest pain
Diagnostic & Treatment
Diagnosis Path: Diagnosis of adverse effects related to cardiac-stimulant glycosides involves a combination of patient history, clinical examination, and laboratory tests. Healthcare providers may consider the following:
Treatment Protocols: Treatment strategies focus on managing symptoms and minimizing further adverse effects, including:
Clinical Advice & FAQs
Billing Guidance
Is T46.0X5 a billable ICD-10 code?
Yes, T46.0X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.0X5?
Clinical documentation must specify the nature of Adverse effect of cardiac-stimulant glycosides and drugs of similar action and any associated comorbidities for accurate reporting.
Cite this Clinical Reference